KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Exchange Rate Effect: 2012-2024

Historic Exchange Rate Effect for Xenon Pharmaceuticals (XENE) over the last 13 years, with Dec 2024 value amounting to -$1.7 million.

  • Xenon Pharmaceuticals' Exchange Rate Effect fell 111.11% to -$6,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$595,000, marking a year-over-year decrease of 121.19%. This contributed to the annual value of -$1.7 million for FY2024, which is 544.68% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Exchange Rate Effect of -$1.7 million as of FY2024, which was down 544.68% from $376,000 recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Exchange Rate Effect registered a high of $376,000 during FY2023, and its lowest value of -$2.5 million during FY2022.
  • In the last 3 years, Xenon Pharmaceuticals' Exchange Rate Effect had a median value of -$1.7 million in 2024 and averaged -$1.3 million.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Exchange Rate Effect surged by 115.14% in 2023, and later plummeted by 544.68% in 2024.
  • Xenon Pharmaceuticals' Exchange Rate Effect (Yearly) stood at -$593,000 in 2020, then rose by 0.17% to -$592,000 in 2021, then tumbled by 319.59% to -$2.5 million in 2022, then skyrocketed by 115.14% to $376,000 in 2023, then slumped by 544.68% to -$1.7 million in 2024.